Peripheral Neuropathies in Human Immunodeficiency Virus Infection
Open Access
- 1 January 2005
- book chapter
- Published by Elsevier BV
Abstract
No abstract availableFunding Information
- National Institutes of Health (AI56297, NS43991, NS46262)
This publication has 96 references indexed in Scilit:
- Schwann cell chemokine receptors mediate HIV‐1 gp120 toxicity to sensory neuronsAnnals of Neurology, 2003
- Painful Sensory NeuropathyThe New England Journal of Medicine, 2003
- FK506 is neuroprotective in a model of antiretroviral toxic neuropathyAnnals of Neurology, 2002
- Autonomic neuropathy and prolongation of QT interval in human immunodeficiency virus infectionClinical Autonomic Research, 1995
- Once-Daily Administration of 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related ComplexThe New England Journal of Medicine, 1990
- 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related ComplexThe New England Journal of Medicine, 1990
- Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2′,3′‐dideoxycytidine (ddc)Muscle & Nerve, 1989
- Necrotizing Vasculitis and HIV Replication in Peripheral NervesThe New England Journal of Medicine, 1989
- Isolation of HTLV-III from Cerebrospinal Fluid and Neural Tissues of Patients with Neurologic Syndromes Related to the Acquired Immunodeficiency SyndromeThe New England Journal of Medicine, 1985
- On the Mechanism of Thrombocytopenic Purpura in Sexually Active Homosexual MenThe New England Journal of Medicine, 1984